Laquinimod sodium

Description

Laquinimod ABR-215062 sodium, an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system. Laquinimod sodium reduces astrocytic NF-?B activation to protect from Cuprizone-induced demyelination. Laquinimod sodium has the potential for relapsing remitting RR and chronic progressive CP forms of multiple sclerosis MS; RRMS or CPMS as well as neurodegenerative diseases research.